Drug Shortage Report for APO-ESOMEPRAZOLE

Last updated on 2021-09-20 History
Report ID 97040
Drug Identification Number 02339102
Brand name APO-ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 30 BLS
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-21
Estimated end date 2021-09-17
Actual end date 2021-09-17
Shortage status Resolved
Updated date 2021-09-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-09-20 French Compare
v11 2021-09-20 English Compare
v10 2021-07-12 French Compare
v9 2021-07-12 English Compare
v8 2021-05-19 French Compare
v7 2021-05-19 English Compare
v6 2020-03-03 French Compare
v5 2020-03-03 English Compare
v4 2020-02-28 French Compare
v3 2020-02-28 English Compare
v2 2019-10-23 French Compare
v1 2019-10-23 English Compare

Showing 1 to 12 of 12